Literature DB >> 11997065

White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosis.

Lalitha Vaithianathar1, Chris R Tench, Paul S Morgan, Xia Lin, Lance D Blumhardt.   

Abstract

T(1) relaxation time (T(1)) provides a quantitative magnetic resonance imaging (MRI) parameter for evaluating tissue damage in the brain. We aimed to measure T(1) in the white matter of patients with multiple sclerosis (MS) and study relationships with cerebral atrophy, T(2) lesion load and clinical parameters. Twenty-six patients with relapsing-remitting MS and sixteen healthy controls were scanned with dual-echo T(2)-weighted, 3-dimensional (3-D) magnetization-prepared rapid acquisition gradient echo and whole brain, multi-slice inversion recovery (IR) sequences. White matter masks were defined on axial T(1) map slices using semi-automated seed growing and normalized 'total white matter' T(1) histograms generated. Atrophy data was obtained using the Cavalieri method of modern design stereology. T(2) lesion volume was also determined using seed growing.T(1) histogram-derived measures (median, peak height, peak position and standard deviation) in MS patients were significantly different (p < 0.0001) from controls. Median T(1) correlated significantly with supratentorial (r = 0.42, p = 0.036), lateral ventricle (r = 0.55, p = 0.004), and T(2) lesion volumes (r = 0.84, p < 0.0001), but not with clinical parameters. Total white matter T(1) provides a robust, quantitative measure of global disease burden in MS, and also correlates significantly with cerebral atrophy. Serial studies are required to determine its potential role as a surrogate marker of disease progression.

Entities:  

Mesh:

Year:  2002        PMID: 11997065     DOI: 10.1016/s0022-510x(02)00044-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.

Authors:  Pascal Sati; Anne H Cross; Jie Luo; Charles F Hildebolt; Dmitriy A Yablonskiy
Journal:  Neuroimage       Date:  2010-03-23       Impact factor: 6.556

2.  Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.

Authors:  H Vrenken; S A R B Rombouts; P J W Pouwels; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

Review 3.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

4.  An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging.

Authors:  Daniel R Messroghli; Andre Rudolph; Hassan Abdel-Aty; Ralf Wassmuth; Titus Kühne; Rainer Dietz; Jeanette Schulz-Menger
Journal:  BMC Med Imaging       Date:  2010-07-30       Impact factor: 1.930

5.  Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.

Authors:  H Vrenken; J J G Geurts; D L Knol; C H Polman; J A Castelijns; P J W Pouwels; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

6.  Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging.

Authors:  Amanda F Mejia; Elizabeth M Sweeney; Blake Dewey; Govind Nair; Pascal Sati; Colin Shea; Daniel S Reich; Russell T Shinohara
Journal:  Neuroimage       Date:  2015-12-28       Impact factor: 6.556

7.  Reduced Myelin Signal in Normal-appearing White Matter in Neuromyelitis Optica Measured by 7T Magnetic Resonance Imaging.

Authors:  I-Jun Chou; Radu Tanasescu; Olivier E Mougin; Penny A Gowland; Christopher R Tench; William P Whitehouse; Bruno Gran; Esmaeil Nikfekr; Basil Sharrack; Gordon Mazibrada; Cris S Constantinescu
Journal:  Sci Rep       Date:  2019-10-07       Impact factor: 4.379

8.  Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.

Authors:  Henrik Lund; Martin Krakauer; Arnold Skimminge; Finn Sellebjerg; Ellen Garde; Hartwig R Siebner; Olaf B Paulson; Dan Hesse; Lars G Hanson
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.